Back to top
more

Dentsply Sirona (XRAY)

(Real Time Quote from BATS)

$23.34 USD

23.34
1,153,939

-0.15 (-0.64%)

Updated Nov 4, 2024 03:55 PM ET

After-Market: $23.33 -0.01 (-0.04%) 4:16 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Merit Medical (MMSI) Beats Q4 Earnings and Revenue Estimates

Merit Medical (MMSI) delivered earnings and revenue surprises of 42% and 3.17%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

DENTSPLY SIRONA (XRAY) to Post Q4 Earnings: What's in Store?

DENTSPLY SIRONA's (XRAY) fourth-quarter results are likely to reflect strong segmental performance.

Dentsply International (XRAY) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Dentsply (XRAY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AMN Healthcare (AMN) to Report Q4 Earnings: What's in Store?

AMN Healthcare's (AMN) fourth-quarter results are likely to reflect solid demand in some of the areas of its business.

OPKO Health (OPK) to Post Q4 Earnings: What's in the Cards?

OPKO Health's (OPK) fourth-quarter results are likely to reflect strength in Rayaldee.

What's in Store for West Pharmaceutical's (WST) Q4 Earnings?

West Pharmaceutical's (WST) fourth-quarter results are likely to reflect strength in the Proprietary Products business.

Baxter (BAX) to Report Q4 Earnings: What's in the Offing?

Baxter's (BAX) fourth-quarter results are likely to reflect growth in its Acute Therapies business.

Why the Earnings Surprise Streak Could Continue for Dentsply (XRAY)

Dentsply (XRAY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Now

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woes persist.

Trina Mukherjee headshot

3 Medical Products Stocks Poised to Beat This Earnings Season

The Medical Products companies' Q4 results are likely to reflect base business recovery. Let's see how BAX, HSIC, and XRAY are poised ahead of their earnings releases.

DaVita's (DVA) Collaboration to Aid in Kidney Care Needs

DaVita's (DVA) work with transplant providers and kidney doctors is likely to slow CKD progression and bolster access to home dialysis and kidney transplantation.

Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Now

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woes persist.

DENTSPLY SIRONA's (XRAY) New Alliance to Boost Digital Dentistry

DENTSPLY SIRONA (XRAY) and 3Shape extend their partnership to simplify digitally oriented workflows for dentists and dental technicians.

Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Now

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woe persists.

DENTSPLY SIRONA (XRAY) Q3 Earnings & Revenues Beat Estimates

DENTSPLY SIRONA's (XRAY) third-quarter results benefit from strong segmental performance.

Dentsply International (XRAY) Q3 Earnings and Revenues Surpass Estimates

Dentsply (XRAY) delivered earnings and revenue surprises of 4.62% and 4.02%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Trina Mukherjee headshot

Medical Products' Nov 4 Earnings Roster: BDX, ZBH & More

The Medical Product companies' Q3 results are likely to reflect huge adoption of their COVID-related support products. Let's see how BDX, ZBH, ABC and XRAY are poised ahead of their earnings releases.

Analysts Estimate Dentsply International (XRAY) to Report a Decline in Earnings: What to Look Out for

Dentsply (XRAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DENTSPLY SIRONA (XRAY) to Post Q3 Earnings: What's in Store?

DENTSPLY SIRONA (XRAY) third-quarter results are likely to reflect strong segmental performance.

Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Now

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woe persists.

XRAY vs. COO: Which Stock Should Value Investors Buy Now?

XRAY vs. COO: Which Stock Is the Better Value Option?

Inogen (INGN) Stock Loses 26.7% In Spite of Q2 Earnings Beat

Inogen's (INGN) second-quarter results benefit from higher revenues across its segments.

LHC Group (LHCG) Stock Loses 11.9% Despite Q2 Earnings Beat

LHC Group's (LHCG) second-quarter results benefit from organic growth in both home health and hospice admissions.

DENTSPLY SIRONA (XRAY) Q2 Earnings & Revenues Beat Estimates

DENTSPLY SIRONA's (XRAY) second-quarter results benefit from strong segmental performance.

Dentsply International (XRAY) Beats Q2 Earnings and Revenue Estimates

Dentsply (XRAY) delivered earnings and revenue surprises of 9.23% and 6.95%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?